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Abstract: The preparation, characterization, and in vitro release of 5-aminosalicylic acid 
(5-ASA) from methacrylic acid (MAA)/perlite composites (APC) prepared via a sol–gel 
route are reported. The free-radical graft polymerization of methacrylic acid (MAA) onto 
perlite particles was studied experimentally. The grafting procedure consisted of surface 
activation with 3-(trimethoxysilyl) propyl methacrylate (TSPA), followed by free-radical 
graft polymerization of methacrylic acid (MAA) in ethyl acetate with 2,2΄-azobis-
isobutyronitrile (AIBN) initiator. The composition of the composites hybrid materials was 
determined by FTIR spectroscopy. Equilibrium swelling studies were carried out in 
enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). The dried 
composites were immersed in a saturated solution of 5-ASA in water overnight and dried 
over a period of three days at room temperature and the in vitro release profiles were 
established separately in both (SGF, pH 1) and (SIF, pH 7.4). The 5-ASA concentration of 
the solution was measured using a UV-Vis spectrophotometer (205 nm) at different time 
intervals. The in vitro drug release test revealed that the release rate of 5-ASA in buffer 
solutions increased with the silica content in the composites; on the contrary, the increase 
of the content of 3-(trimethoxysilyl)propyl methacrylate (TSPA), a coupling agent, 
decreased the drug release rate. 
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1. Introduction 
 
Mineral clays of the smectite group present a set of structural characteristics that make them 
attractive for the development of catalysts, sorbents, supports for drug or enzymes, and intercalation of 
organic molecules
 [1–5]. Organosilanes are widely used for the modification of silica surfaces. The 
silylation mechanism for the attachment of organosilane to amorphous silica and alumina surfaces has 
been commonly reported [6–8]. Recently, organosilanes have been employed for the modification of 
layered silicates, with smectites and vermiculites being the most commonly clays used to investigate 
the functionalization processes [9–12]. Organo-functional silanes, represented as RSiX3, are often used 
as coupling agents to enhance the adhesion between polymer and silica filler. The methoxy or ethoxy 
groups, represented by X, can be hydrolyzed with water. The silanol groups of hydrolyzed coupling 
agents can be condensed with other silanol groups on a glass or ceramic surface. The organo-
functional group, R, can be bonded chemically to a polymer matrix. Thus, the adhesion between 
polymer and inorganic fillers was improved due to the chemical bonds that formed at the interface. To 
our best knowledge, how the interface inside organic–inorganic composite materials as well as the 
coupling agents affect the drug release property has not been studied. Understanding the interfacial 
interactions and structure is important to better design and application of organic–inorganic composite 
drug delivery systems. 
Perlite is an attractive material as drug carriers because of its stability over a fairly wide range of 
pH (excluding alkaline), relative inertness in many environments, and transparency in the UV-visible 
spectrum. Perlites are amorphous aluminum silicates with high content of silica more than 70%. 
Commercially, the term perlite is used describe either natural or expanded perlite which formed by 
heating quickly [13]. Inorganic support materials including silica gels, alumina, zeolite and perlite are 
focused due to their thermal and mechanical stability, no-toxicity and high resistance against 
environment pH [14]. Lots of inorganic support materials, however, have too expensive cost because 
of being synthesized from organism-silicon compounds, such as recently developed materials   
MCM-41, SBA-15, meso-cellular foams [15]. Here the advantage of perlite instead of the other 
supports is more inexpensive than the other supports [16]. 
 
2. Results and Discussion  
 
In the present study perlite was selected for drug delivery support. Organic/inorganic composite 
were synthesized by graft copolymerization of MAA onto TSPA-modified silica particles (variable 
feed ratio as shown in Table 1) in a solution of ethyl acetate (Scheme 1). In this step, the formation of 
grafted polymer chains is typically attributed to both propagation of growing surface chains (surface 
propagation) and coupling termination between growing homopolymer chains and growing surface 
chains (polymer grafting) [17].  
5-aminosalicylic acid (5-ASA) is useful for localized chemotherapy of inflammatory bowel disease 
(IBD), but this drug is likely to be absorbed or degraded in the stomach and small intestine before 
reaching the colon sites [18]. 5-ASA was loaded into these organic/inorganic composite and in vitro 
release profiles were established separately in enzyme-free simulated gastric and intestinal fluids (SGF     Int. J. Mol. Sci. 2010  
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and SIF, respectively). Influences of different factors, such as content of MAA and swelling   
were studied. 
Table 1. The molar composition of composite. 
Organic/inorganic 
composite   
Molar composition in the feed (%)
TSPA                     MAA   
APC-1  
APC-2  
APC-3   
APC-4   
5                             10    
5                             30     
10                           10  
10                           30  
 
Scheme 1. Surface modification of perlite: (a) silylation with TSPA and (b) graft 
polymerization with MAA. 
 
 
Grafting the polymer above 70 °C was not feasible due to a rapid volatilization of the ethyl acetate 
solvent (bp = 77 °C) accompanied by a relatively high rate of conversion. Each grafting experiment 
was performed by adding TSPA-modified particles into a predetermined volume of MAA/ethyl acetate 
solution. The slurry mixture was then heated to a desired temperature followed by the addition of an 
appropriate amount of the AIBN initiator. 
 
2.1. Analyses of Extent Interactions between Organic and the Inorganic Moieties  
 
It is important to know whether, and to what extent, the reaction between the silica particles and the 
polymer matrix has occurred. Therefore, THF extractions of PMAA/perlite composite were performed 
for 10 days to evaluate the interaction between organic and inorganic phases. If there were no strong 
interactions between PMAA and the inorganic moieties, THF, a good solvent for PMAA would 
dissolve the polymer and leave the inorganic component whose weight will almost equal to the amount 
of silica used in the composites. The resulting values of the residue percentage were listed in Table 2. 
When 5% (v/v) TSPA was introduced, the residue jumped to 88% and increased with increasing 
amount of TSPA (10% (v/v)) in composites (97%). That is to say, with the existence of TSPA in the     Int. J. Mol. Sci. 2010  
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composites, strong chemical bonds were formed between polymer and silica particles. The 
crosslinking between organic and inorganic phases was strengthened, and silica particles were not 
easily ‘‘drop off’’ from composites with TSPA. 
 
  2.2. Thermal Behavior 
 
The thermal behavior of polymer composites is important in relation to its properties for controlling 
the release rate in order to have a suitable drug dosage form. Differential scanning calorimetry (DSC) 
was used for analysis of composites. The glass transition temperature (Tg) was determined from the 
DSC thermograms. As shown in Table 2, the higher Tg values are probably related to the presence of 
silica particles as well as the coupling agent TSPA, which would decrease the flexibility of the 
composites and the ability of the composites to undergo segmental motion, which would increase the 
Tg values.  
Diffusion rate of small molecules through polymer matrix is often lowered with the increasing Tg 
for the increasing restriction of chain-segment mobility. Since 5-ASA is also a small molecule, Tg may 
influence the 5-ASA release behaviors of PMAA/perlite composites. However, the Tg of each 
composite in this study is above 150 °C, which is much higher than the temperature of release study. 
Therefore, the effect of Tg difference may be less important for drug release study. 
 
Table 2. DSC data and THF extraction results.   
Organic/inorganic 
composite   
Tg (°C)    Residue (%)   
APC-1  
APC-2  
APC-3   
APC-4   
150  
162  
180  
195  
97  
93  
88  
83  
 
2.3. Swelling of Composite 
 
The swelling value of organic/inorganic composite in pH 1 and pH 7.4 at 37 °C for 2 days are given 
in Table 3. In this study, the swelling ratio (SR) of the prepared composite samples was determined in 
order to know whether SR would influence their drug release properties [19,20]. It has been reported 
that in organic/inorganic composite, water-uptake mainly occurs in the organic phase matrix [21]. In 
these composite, an increase in the content of MAA in the feed monomer mixtures resulted in less 
swelling in SGF but greater swelling in SIF. The loading numbers in Table 3 shows which that 
existence of polar functional groups such as carboxylic acid are needed not only for loading drug on 
the polymer but also for pH-sensitive properties of the polymer. The hydrogen-bonding and 
electrostatic interactions increased with MAA content in the copolymer networks. Because the 
increase of MAA content in the hydrogels provides more hydrogen bonds at low pH and more 
electrostatic repulsion at high pH.     Int. J. Mol. Sci. 2010  
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Table 3. Percent of swelling and drug loading numbers.   
Composites  
Maximum constant 
swelling (%) pH 1  
Maximum constant 
swelling (%) pH 7.4
Percent of 5-ASA-
loading (%)  
APC-1  
APC-2  
APC-3   
APC-4   
8  
5  
4  
2  
26  
35  
22  
30   
87  
96  
78   
90  
 
Use of TSPA remarkably reduced equilibrium water uptake for TSPA-modified samples. This 
reduction should be attributed to the improved interfacial adhesion that avoided an easy penetration of 
water molecules into the modified composites and reduced water accumulation in interfacial   
voids [22,23]. With increased cross-linking and an increase in the reticulated degree of the polymer, 
diffusion of the water in the network’s polymer is reduced and the swelling is slower. 
 
2.4. Release Studies 
 
Although oral delivery has become a widely accepted route of administration of therapeutic drugs, 
the gastrointestinal tract presents several formidable barriers to drug delivery. Colonic drugs delivery 
has gained increased importance not just for the delivery of the drugs for the treatment of local 
diseases associated with the colon but also for its potential for the delivery of proteins and therapeutic 
peptides. To achieve successful colonic delivery, a drug needs to be protected from absorption of the 
environment of the upper gastrointestinal tract (GIT) and then be abruptly released into the proximal 
colon, which is considered the optimum site for colon-targeted delivery of drugs. 
Among the various methods that have been developed to assist to these problems [24–30], use of 
environmentally sensitive hydrogels, especially pH-sensitive carriers, is the most promising method. 
The objective of this study is to utilize the pH sensitivity composite for oral drug delivery. Then, the 
grafting of acrylic monomers onto perlite could result in combined properties such as 
biocompatability, nontoxicity, and higher bioadhesion, which would confer attractive characteristics 
on the newly prepared composite materials [31].  
In order to study potential application of APC containing 5-ASA as a pharmaceutically active 
compound, we have studied the drug releases behavior of the composite under physiological 
conditions. Although the composites were not soluble in water, they were dispersed in a buffer 
solution, and the drug release was evaluated as a heterogeneous system. The percent of released drug 
from organic/inorganic carriers by different amount of TSPA and MAA as a function of time is shown 
in Figure 1. The concentration of 5-ASA released at selected time intervals was determined by UV 
spectrophotometry at 205 nm. 
It can be seen that the drug release rate decreased with the increasing content of TSPA. The samples 
with TSPA had higher crosslinking densities, they had blurred interface between polymer matrix and 
silica particles, indicating the better adhesion between two phases. And this would decrease diffusion 
path of drug and leads to slower drug release rate. The other mechanism is the crosslinking effect of 
the TSPA to the polymer matrix. Besides the improvement of interfacial adhesion between polymer 
matrix and silica, TSPA has also crosslinking effect to the polymer chains. With higher TSPA content,     Int. J. Mol. Sci. 2010  
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the mobility of the polymer chains were limited, this may result in decreased diffusion rate of small 
molecules like drug within the polymer matrix. This might be the reason why the drug release of 
samples with 5% and 10% coupling agent were different while their SR values were nearly equivalent 
according to Figure 1. 
As the content of MAA in the feed monomers increased, hydrolysis rate decreased at pH 1 but 
increased at pH 7.4. This was because a higher MAA content in the polymer networks led to higher 
carboxylate anion concentration at high pH. In other words, the existence of hydrogen-bonding 
interactions between –COOH groups in the polymer matrix results in a complex structure within the 
network, and so the movement of polymeric segments is restricted. In other hand, Figure 1 clearly 
shows a release amount at the beginning of the release process at pH 1 is approximately 10%. In drug 
loading, adsorption of drug molecule can be occurred in and on the composites. It has been established 
that the release of adsorb drug molecules on composite surface is very fast.  
 
Figure 1. Release of 5-ASA from composites as a function of time at 37 °C.  
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This also accounts for minimum hydrolyzing of the gel in a medium of pH 1. However, when the 
sample is placed in a medium of pH 7.4, the almost complete ionization of –COOH groups present 
within the polymer network not only increases the ion osmotic swelling pressure to a great extent but 
also enhances the relaxation of macromolecular chains because of repulsion among similarly   
charged –COO
- groups. These two factors ultimately result in a greater increase in the water uptake. In 
pH 7.4 with completed ionization and an increase in the hydrophilicity of the polymer, diffusion of the 
hydrolyzing agents on polymer is increased and the hydrolysis rate increased [32]. 
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3. Experimental 
 
Surface graft polymerization of MAA onto perlite particles was carried out via a two-step process: 
surface activation (TSPA) followed by graft polymerization of MAA in ethyl acetate   
with 2,2’-azobisisobutyronitrile (AIBN) initiator. 
 
3.1. Materials 
 
3-(Trimethoxysilyl)propyl methacrylate (TSPA, 99%) was purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Methacrylic acid (MAA) and 2,2΄-azobisisobutyronitrile (AIBN) were purchased 
from Merck (Darmstadt, Germany). All other chemicals were of analytical grade and were purchased 
from Fluka (Tokyo, Japan). Perlite obtained from Kan Azar Tabriz Co. (Tabriz, Iran). Methacrylic acid 
was purified by distillation under vacuum. Initiator of 2,2΄-azobisisobutyronitrile (AIBN) was purified 
by crystallization from methanol.  
The IR spectra were recorded on a Shimadzu FT IR-408 spectrophotometer. The DSC curves were 
obtained on a TGA/SDTA 851 calorimeter at heating and cooling rates of 10 °C/min under N2. The 
amount of released drug was determined on a Philips PU 8620 UV spectrophotometer at the absorption 
maximum of the free drug in aqueous alkali (λmax = 205 nm) using a 1 cm quartz cell. The HPLC 
apparatus (Bischoff, Germany) consisted of Bruker LC-21, equipped with a Bruker UV-Vis detector 
model LC 313 I, Rheodyne loop injector and a C18 reversephase column of Spherisorb-CN   
(250 × 4.6 mm id., particle size 5 μm). 
 
3.2. Silylation 
 
After separating fine perlite powder of special mesh size with a sieve, 25 g of dry perlite were 
washed by stirring overnight in methanol to remove any organic contaminant and then washed by 
distilled water. After that 5N NaOH was added to the cleaned perlite and the solution was heated for 
30 min in a boiling water bath. Precipitated perlite were filtered and rinsed with excess water until 
NaOH removed and the washed water reached pH 7. Perlite powder was suspended in two freshly 
prepared solution of TSPA (5 and 10% (v/v) in 50 mM acetate buffer, pH 4.0. The suspensions were 
incubated at 75 °C for 4 h with constant mixing then washed thoroughly with abundant water in order 
to remove TSPA molecules not linked to the surface of support. IR (KBr): 1,730, 1,640, 1,455, 1,260, 
1,087, 817 cm
-1.  
 
3.3. Graft Polymerization 
 
Organic/inorganic composite were synthesized by graft copolymerization of MAA onto TSPA-
modified silica particles (variable feed ratio as shown in Table 1) in a solution of ethyl acetate. 
Copolymerization was carried out in the presence of 2,2´-azobisisobutyronitrile (AIBN) as an initiator 
(0.02 mol·L
-1) at 60–70 °C in a thermostatic water bath. All experiments were carried out in Pyrex 
glass ampoules sealed off under vacuum. The conversion of monomer into polymer was determined by 
UV spectral analysis. After the desired time (24 h) the composites was collected, washed with     Int. J. Mol. Sci. 2010  
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deionized water for one day and the water was changed every six hours in order to remove any 
unreacted monomers. After washing, the samples were dried in air and stored in desiccators until use. 
IR (KBr): 3,350–2,550 (broadened, -COOH group), 1,725, 1,456, 1,258, 1,119, 890 cm
-1.   
 
3.4. The Swelling Ratio of Matrices 
 
In a typical test, the films after having been soaked in various buffer solutions (pH 7.4 and pH 1) at 
37 °C for two days were weighed after excess water was wiped off from the film surface with filter 
paper. The swelling ratio (SR) of matrices was calculated using the following equation: 
SW (%) = [(Ws - Wd)/Wd] × 100          (1) 
where Ws and Wd represent the weight of swollen and dry samples, respectively. 
 
3.5. Drug Loading in Composites 
 
Subsequently, 100 mg of each matrix was placed in 10 mL of 5-aminosalicylic acid (5-ASA)   
(10 mg·mL
-1) to suck up the total amount of the drug solution. After approximately 6 h, the swollen 
composits loaded with drug were placed in desiccators and dried under vacuum at room temperature.  
 
3.6. Determination of the Amount of Drug Entrapped 
 
The amount of drug entrapped in the composite was determined by an indirect method. After the gel 
preparation, the washings were collected, filtered and tested using UV–VIS spectroscopy. The 
difference between the amount of drug initially employed and the drug content in the washings is taken 
as an indication of the amount of drug entrapped. The values of quantification of entrapped drug in the 
composite based on the total amount are given in Table 3.  
 
3.7. Characterization of Hydrolysis Product 
 
Composite-drug adduct (90 mg) was dispersed in 20 mL of pH 8 buffered solution. The reaction 
mixture was maintained at 37 °C. After 24 h the hydrolysis solution was sampled and neutralized with 
1 M HCl and the solvent was evaporated in vacuum. The resulting crude product was treated with  
20 mL of mixture (1:1) of acetone: H2O and heated. The suspension was then filtered and the solution 
was evaporated under reduced pressure. Samples were measured using HPLC-UV. The column used 
was ODS (C18) and isocratic elution was performed using 50% methanol and 50% buffer containing 
0.05 M NH3. The flow-rate and injection volume were 1 mL/min and 100 μL, respectively. 5-ASA was 
detected at a retention time of 2.4 min. 
 
3.8. In Vitro Drug Release Study 
 
Each drug-loaded composite sample was soaked in 5 mL of aqueous buffer solution (SGF: pH 1 or 
SIF: pH 7.4). The mixture was introduced into a cellophane membrane dialysis bag. The bag was 
closed and transferred to a flask containing 20 mL of the same solution maintained at 37 °C for 24 h.     Int. J. Mol. Sci. 2010  
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The external solution was continuously stirred, and 3 mL samples were removed at selected intervals. 
5-ASA content in the buffer solutions was measured by UV-Visible spectrophotometer at the 
wavelength λmax = 205 nm. All the drug release studies were carried out in triplicate. 
 
4. Conclusions 
 
In this study, PMAA/perlite composite materials with various TSPA proportion and perlite content 
have been prepared via sol–gel process. The influence of TSPA proportion and MAA content on their 
drug release properties has been evaluated using 5-ASA as a model drug. The swelling test supported 
the hypothesis that the interface between the polymer matrix and silica particles played a key role in 
drug release property of the composite system. The drug release rate increased with the increasing 
content of perlite while decreased with the amount of coupling agent in the composite samples. The 
drug release rate of this composite system can be modulated by adjusting the content of both inorganic 
fillers and the coupling agent.  
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